FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer

被引:160
作者
Baker, M. J. [1 ]
Gazi, E. [2 ]
Brown, M. D. [2 ]
Shanks, J. H. [3 ]
Gardner, P. [1 ]
Clarke, N. W. [2 ,4 ,5 ]
机构
[1] Univ Manchester, Sch Chem Engn & Analyt Sci, Ctr Instrumentat & Analyt Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England
[2] Univ Manchester, Paterson Inst Canc Res, Sch Canc & Imaging Sci, Genito Urinary Canc Res Grp, Manchester M20 4BX, Lancs, England
[3] Christie Hosp NHS Fdn Trust, Dept Histopathol, Manchester M20 4BX, Lancs, England
[4] Christie Hosp NHS Fdn Trust, Dept Urol, Manchester M20 4BX, Lancs, England
[5] Salford Royal NHS Fdn Trust, Dept Urol, Salford M6 8HD, Lancs, England
基金
英国工程与自然科学研究理事会; 英国医学研究理事会;
关键词
FTIR microspectroscopy; prostate cancer; molecular diagnosis; Gleason grade; PC-DFA; infrared spectroscopy;
D O I
10.1038/sj.bjc.6604753
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fourier transform infrared (FTIR) spectroscopy is a vibrational spectroscopic technique that uses infrared radiation to vibrate molecular bonds within the sample that absorbs it. As different samples contain different molecular bonds or different configurations of molecular bonds, FTIR allows us to obtain chemical information on molecules within the sample. Fourier transform infrared microspectroscopy in conjunction with a principal component-discriminant function analysis (PC-DFA) algorithm was applied to the grading of prostate cancer (CaP) tissue specimens. The PC-DFA algorithm is used alongside the established diagnostic measures of Gleason grading and the tumour/node/metastasis system. Principal component-discriminant function analysis improved the sensitivity and specificity of a three-band Gleason score criterion diagnosis previously reported by attaining an overall sensitivity of 92.3% and specificity of 99.4%. For the first time, we present the use of a two-band criterion showing an association of FTIR-based spectral characteristics with clinically aggressive behaviour in CaP manifest as local and/or distal spread. This paper shows the potential for the use of spectroscopic analysis for the evaluation of the biopotential of CaP in an accurate and reproducible manner.
引用
收藏
页码:1859 / 1866
页数:8
相关论文
共 21 条
[1]  
ALBERTSEN PC, 2005, JAMA-J AM MED ASSOC, V17, P2095
[2]  
[Anonymous], UROLOGIC PATHOLOGY
[3]   Discrimination of prostate cancer cells and non-malignant cells using secondary ion mass spectrometry [J].
Baker, Matthew J. ;
Brown, Michael D. ;
Gazi, Ehsan ;
Clarke, Noel W. ;
Vickerman, John C. ;
Lockyer, Nicholas P. .
ANALYST, 2008, 133 (02) :175-179
[4]   Fourier transform infrared imaging and unsupervised hierarchical clustering applied to cervical biopsies [J].
Bambery, KR ;
Wood, BR ;
Quinn, MA ;
McNaughton, D .
AUSTRALIAN JOURNAL OF CHEMISTRY, 2004, 57 (12) :1139-1143
[5]   A distinct utility of the amide III infrared band for secondary structure estimation of aqueous protein solutions using partial least squares methods [J].
Cai, SW ;
Singh, BR .
BIOCHEMISTRY, 2004, 43 (09) :2541-2549
[6]   A decade of vibrational micro-spectroscopy of human cells and tissue (1994-2004) [J].
Diem, M ;
Romeo, M ;
Boydston-White, S ;
Miljkovic, M ;
Matthäus, C .
ANALYST, 2004, 129 (10) :880-885
[7]   FTIR spectroscopy studies of nucleic acid damage [J].
Dovbeshko, GI ;
Gridina, NY ;
Kruglova, EB ;
Pashchuk, OP .
TALANTA, 2000, 53 (01) :233-246
[8]   Diagnosing benign and malignant lesions in breast tissue sections by using IR-microspectroscopy [J].
Fabian, Heinz ;
Thi, Ngoc Anh Ngo ;
Eiden, Michael ;
Lasch, Peter ;
Schmitt, Juergen ;
Naumann, Dieter .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (07) :874-882
[9]   The combined application of FTIR microspectroscopy and ToF-SIMS imaging in the study of prostate cancer [J].
Gazi, E ;
Dwyer, J ;
Lockyer, N ;
Gardner, P ;
Vickerman, JC ;
Miyan, J ;
Hart, CA ;
Brown, M ;
Shanks, JH ;
Clarke, N .
FARADAY DISCUSSIONS, 2004, 126 :41-59
[10]   Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot study [J].
Gazi, E ;
Dwyer, J ;
Gardner, P ;
Ghanbari-Siahkali, A ;
Wade, AP ;
Miyan, J ;
Lockyer, NP ;
Vickerman, JC ;
Clarke, NW ;
Shanks, JH ;
Scott, LJ ;
Hart, CA ;
Brown, M .
JOURNAL OF PATHOLOGY, 2003, 201 (01) :99-108